LINDEN ADVISORS LP - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is and the CUSIP is 88165UAB5. A total of 10 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$675,000
-48.2%
7,500,0000.0%0.03%
-45.6%
Q2 2016$1,302,000
-39.1%
7,500,0000.0%0.06%
-51.7%
Q1 2016$2,139,000
-32.4%
7,500,0000.0%0.12%
-38.2%
Q4 2015$3,164,000
-21.5%
7,500,0000.0%0.19%
-31.0%
Q3 2015$4,030,000
-10.4%
7,500,0000.0%0.28%
-48.2%
Q2 2015$4,497,0007,500,0000.54%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q2 2016
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 3,000,000$454,0000.24%
Cormorant Asset Management, LP 5,000,000$856,0000.12%
LINDEN ADVISORS LP 7,500,000$1,302,0000.06%
WHITEBOX ADVISORS LLC 10,804,000$1,634,0000.04%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,000,000$323,0000.02%
Hudson Bay Capital Management LP 1,000,000$223,0000.01%
LAZARD ASSET MANAGEMENT LLC 8,500,000$1,455,0000.00%
NOMURA HOLDINGS INC 3,196,000$483,0000.00%
CREDIT AGRICOLE S A 586,000$89,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 2,750,000$442,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders